These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4823806)

  • 1. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
    Antcliff AC; Bouhoutsos J; Martin P; Morris T
    Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
    Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
    J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 4. An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud's phenomenon.
    Holti G
    J Int Med Res; 1979; 7(6):473-83. PubMed ID: 391622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is iloprost effective in secondary Raynaud's phenomenon?
    Lustig N; Rada G
    Medwave; 2015 Mar; 15(2):e6082. PubMed ID: 25826330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
    Cristol R; Graisely B; Cloarec M; Debray J
    Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
    DiGiacomo RA; Kremer JM; Shah DM
    Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plethysmographic measurement of digital blood flow in Raynaud's phenomenon caused by vibrating tools].
    Casula D; Nissardi GP; Sanna-Randaccio F; Torrazza PL
    Minerva Cardioangiol; 1969 Jun; 17(6):386-98. PubMed ID: 5385423
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor.
    Seibold JR; Jageneau AH
    Arthritis Rheum; 1984 Feb; 27(2):139-46. PubMed ID: 6365102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of vasodilator agents and of indirect heating in Raynaud's disease.
    Hansteen V
    Scand J Clin Lab Invest Suppl; 1973; 128():211-2. PubMed ID: 4764583
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and physiological studies of Raynaud's phenomenon.
    Engelhart M
    Dan Med Bull; 1991 Dec; 38(6):458-68. PubMed ID: 1802635
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
    Cristol R; Debray J
    J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetranicotinoylfructose in disorders of digital blood flow.
    Holti G; Newell DJ; Poole HG
    Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
    Engelhart M; Seibold JR
    Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
    Gross R; Galus K; Zajac S; Jedrasik M
    Wiad Lek; 2002; 55(1-2):29-34. PubMed ID: 12043312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of capillary circulation: Raynaud's disease.
    Arnot RS; Boroda C; Peacock JH
    Angiology; 1978 Jan; 29(1):48-52. PubMed ID: 343651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.